Key players in Lysosomal Storage Disease Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Sanofi |
sanofi.com (opens in a new tab) | 1,386 reports |
| 2 |  Takeda Pharmaceutical Company Ltd |
takeda.com (opens in a new tab) | 660 reports |
| 3 | BioMarin | — | 165 reports |
| 4 | Amicus Therapeutics | — | 66 reports |
| 5 | Chiesi | — | 99 reports |
Lysosomal Storage Disease Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Lysosomal Storage Disease Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.